Skip to menu Skip to content Skip to footer

2019

Conference Publication

The epidemiology of amyloidosis in Australia

Wisniowski, Brendan, McLeod, Donald, Adams, Rebecca, Harvey, Yasmin, Armes, Jane, Papadimos, David, Brown, Ian, McGuire, Lloyd and Mollee, Peter (2019). The epidemiology of amyloidosis in Australia. XVI International Symposium on Amyloidosis, Kumamoto, Japan, 26-29 March 2018. Abingdon, Oxfordshire United Kingdom: Taylor & Francis. doi: 10.1080/13506129.2019.1582481

The epidemiology of amyloidosis in Australia

2019

Journal Article

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

Chin, C. K., Tsang, E., Mediwake, H., Khair, W., Biccler, J., Hapgood, G., Mollee, P., Nizich, Z., Joske, D., Radeski, D., Cull, G., Villa, D., El-Galaly, T. C. and Cheah, C. Y. (2019). Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement. British Journal of Haematology, 184 (5), 826-828. doi: 10.1111/bjh.15173

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

2019

Journal Article

Proposed addendum to 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand

Tate, Jillian R., Smith, Joel D., Wijeratne, Nilika and Mollee, Peter (2019). Proposed addendum to 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand. Clinical Biochemist Reviews, 40 (1), 23-30.

Proposed addendum to 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand

2019

Journal Article

Response to article by Caponi et al. about serum free light chains

Tate, Jillian R., Hawley, Carmel and Mollee, Peter (2019). Response to article by Caponi et al. about serum free light chains. Clinical Chemistry and Laboratory Medicine, 57 (2), e1-e2. doi: 10.1515/cclm-2018-0994

Response to article by Caponi et al. about serum free light chains

2019

Conference Publication

Beta-migrating paraproteins: a need for harmonisation of reporting

Wijeratne, Nilika, Tate, Jillian R., Du Toit, Stephen, Smith, Joel D., Soepnel, Andrew, Choy, Kay Weng, Martin, Helen, Henry, Robyn, Glegg, Kaye, Byrnes, Elizabeth, Wienholt, Louise and Mollee, Peter (2019). Beta-migrating paraproteins: a need for harmonisation of reporting. Pathology Update 2019, Melbourne, VIC Australia, 22-24 February 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2018.12.323

Beta-migrating paraproteins: a need for harmonisation of reporting

2019

Journal Article

Paraprotein sample exchange in Australia and New Zealand - 2018

Wijeratne, Nilika, Tate, Jillian R., Toit, Stephen Du, Smith, Joel D., Soepnel, Andrew, Choy, Kay Weng, Martin, Helen, Henry, Robyn, Glegg, Kaye, Byrnes, Elizabeth, Wienholt, Louise and Mollee, Peter (2019). Paraprotein sample exchange in Australia and New Zealand - 2018. Clinical Biochemist Reviews, 40 (1), 43-54.

Paraprotein sample exchange in Australia and New Zealand - 2018

2019

Journal Article

Amyloidosis in Australia

Mollee, Peter, Gibbs, Simon and Stewart, Graeme (2019). Amyloidosis in Australia. Expert Opinion on Orphan Drugs, 7 (2), 37-39. doi: 10.1080/21678707.2019.1563539

Amyloidosis in Australia

2019

Journal Article

Report of the survey conducted by RCPAQAP on current practice for paraprotein and serum free light chain measurement and reporting: A need for harmonisation

Wijeratne, Nilika, Tate, Jillian R., Wienholt, Louise and Mollee, Peter (2019). Report of the survey conducted by RCPAQAP on current practice for paraprotein and serum free light chain measurement and reporting: A need for harmonisation. Clinical Biochemist Reviews, 40 (1), 31-42.

Report of the survey conducted by RCPAQAP on current practice for paraprotein and serum free light chain measurement and reporting: A need for harmonisation

2019

Journal Article

Correction to: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group (Nature Reviews Nephrology, (2019), 15, 1, (45-59), 10.1038/s41581-018-0077-4)

Leung, Nelson, Bridoux, Frank, Batuman, Vecihi, Chaidos, Aristeidis, Cockwell, Paul, D’Agati, Vivette D., Dispenzieri, Angela, Fervenza, Fernando C., Fermand, Jean- Paul, Gibbs, Simon, Gillmore, Julian D., Herrera, Guillermo A., Jaccard, Arnaud, Jevremovic, Dragan, Kastritis, Efstathios, Kukreti, Vishal, Kyle, Robert A., Lachmann, Helen J., Larsen, Christopher P., Ludwig, Heinz, Markowitz, Glen S., Merlini, Giampaolo, Mollee, Peter, Picken, Maria M., Rajkumar, Vincent S., Royal, Virginie, Sanders, Paul W., Sethi, Sanjeev, Venner, Christopher P. ... Nasr, Samih H. (2019). Correction to: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group (Nature Reviews Nephrology, (2019), 15, 1, (45-59), 10.1038/s41581-018-0077-4). Nature Reviews Nephrology, 15 (2), 121-121. doi: 10.1038/s41581-018-0102-7

Correction to: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group (Nature Reviews Nephrology, (2019), 15, 1, (45-59), 10.1038/s41581-018-0077-4)

2019

Book Chapter

Cast nephropathy

Hutchison, Colin A. and Mollee, Peter (2019). Cast nephropathy. Onco-nephrology. (pp. 59-66.e3) edited by Kevin W. Finkel, Mark A. Perazella and Eric P. Cohen. Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-323-54945-5.00016-3

Cast nephropathy

2019

Journal Article

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia

Enya Chen, Yu-Chen, Burgess, Melinda, Mapp, Sally, Mollee, Peter, Gill, Devinder, Blumenthal, Antje and Saunders, Nicholas A. (2019). PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia. Leukemia, 34 (2), 451-461. doi: 10.1038/s41375-019-0556-z

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia

2019

Journal Article

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

Leung, Nelson, Bridoux, Frank, Batuman, Vecihi, Chaidos, Aristeidis, Cockwell, Paul, D’Agati, Vivette D., Dispenzieri, Angela, Fervenza, Fernando C., Fermand, Jean-Paul, Gibbs, Simon, Gillmore, Julian D., Herrera, Guillermo A., Jaccard, Arnaud, Jevremovic, Dragan, Kastritis, Efstathios, Kukreti, Vishal, Kyle, Robert A., Lachmann, Helen J., Larsen, Christopher P., Ludwig, Heinz, Markowitz, Glen S., Merlini, Giampaolo, Mollee, Peter, Picken, Maria M., Rajkumar, Vincent S., Royal, Virginie, Sanders, Paul W., Sethi, Sanjeev, Venner, Christopher P. ... Nasr, Samih H. (2019). The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nature Reviews Nephrology, 15 (1), 45-59. doi: 10.1038/s41581-018-0077-4

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

2019

Journal Article

Bilateral amyloidoma of the trigeminal nerve causing a progressive trigeminal neuropathy: An unusual presentation of localised AL amyloidosis involving the peripheral nervous system

Lyons, Alexandra, Schweitzer, Daniel, Robertson, Thomas, Mollee, Peter, Tsahtsarlis, Antonio, Mitchell, Roger and Wong, David (2019). Bilateral amyloidoma of the trigeminal nerve causing a progressive trigeminal neuropathy: An unusual presentation of localised AL amyloidosis involving the peripheral nervous system. Neurology and Neurosurgery, 2 (2). doi: 10.15761/nns.1000124

Bilateral amyloidoma of the trigeminal nerve causing a progressive trigeminal neuropathy: An unusual presentation of localised AL amyloidosis involving the peripheral nervous system

2019

Conference Publication

Development of an individualized, supervised exercise intervention as standard care for patients with Multiple Myeloma

Nicol, Jennifer, Woodrow, Carmel, Burton, Nicola, Hill, Michelle, Skinner, Tina, Mollee, Peter and Nicol, Andrew (2019). Development of an individualized, supervised exercise intervention as standard care for patients with Multiple Myeloma. 17th International Myeloma Workshop, Boston, MA, United States, 12-15 September 2019. New York, United States: Elsevier. doi: 10.1016/j.clml.2019.09.355

Development of an individualized, supervised exercise intervention as standard care for patients with Multiple Myeloma

2018

Journal Article

A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AML

Schwarer, Anthony P., Butler, Jason, Jackson, Kathryn, Beligaswatte, Ashanka, Martin, Louisa, Kennedy, Glen, Daniela, Zantomio, Lewis, Ian, Hiwase, Devendra, Wight, Joel, He, Simon, Grigg, Andrew, Morris, Kirk, Mollee, Peter and Marlton, Paula (2018). A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere, 2 (6) e158, 1-8. doi: 10.1097/HS9.0000000000000158

A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AML

2018

Journal Article

Response to Letter to the Editor about immunochemical measurement of urine free light chains

Tate, Jillian R. and Mollee, Peter (2018). Response to Letter to the Editor about immunochemical measurement of urine free light chains. Clinical Chemistry and Laboratory Medicine, 57 (2), e3-e4. doi: 10.1515/cclm-2018-1082

Response to Letter to the Editor about immunochemical measurement of urine free light chains

2018

Journal Article

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

Zimmermann, Heiner, Babel, Nina, Dierickx, Daan, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M., Dreyling, Martin H., Dührsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Hüttmann, Andreas, Tousseyn, Thomas, Bachy, Emmanuel, Hauser, Ingeborg A., Tarella, Corrado, Van Den Neste, Eric, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno, Choquet, Sylvain and Trappe, Ralf U. (2018). Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials. Transplantation, 102 (11), 1914-1923. doi: 10.1097/TP.0000000000002269

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

2018

Journal Article

Pomalidomide – author reply

Scott, Ashleigh P. and Mollee, Peter (2018). Pomalidomide – author reply. Leukemia and Lymphoma, 60 (4), 1-1. doi: 10.1080/10428194.2018.1516884

Pomalidomide – author reply

2018

Journal Article

Relative survival of patients with lymphoma in Queensland according to histological subtype

Wright, Fraser, Hapgood, Greg, Loganathan, Aravi, Dunn, Nathan, Philpot, Shoni, Moore, Julie and Mollee, Peter (2018). Relative survival of patients with lymphoma in Queensland according to histological subtype. Medical Journal of Australia, 209 (4), 166-172. doi: 10.5694/mja17.00937

Relative survival of patients with lymphoma in Queensland according to histological subtype

2018

Journal Article

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma

Quach, Hang, Benson, Simon, Haysom, Helen, Wilkes, Anne-Marie, Zacher, Nicole, Cole-Sinclair, Merrole, Miles Prince, Henry, Mollee, Peter, Spencer, Andrew, Joy Ho, Phoebe, Harrison, Simon J, Lee, Cindy, Augustson, Bradley and Daly, James (2018). Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma. Internal Medicine Journal, 48 (2), 210-220. doi: 10.1111/imj.13707

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma